Class 4 Medicines Notification: Rabeprazole Sodium 10mg And 20mg Gastro-resistant Tablets, El(25)a/01
Recall Summary Bristol Laboratories is recalling certain batches of Rabeprazole sodium 10mg and 20mg gastro-resistant tablets in the UK because the patient information leaflets included with these medications do not contain the latest safety information. This is a Class III recall affecting the information provided to patients, not the medication itself. The recall applies to specific batches listed by the manufacturer and distributed in the United Kingdom.
- Recalling firm
- Rabeprazole sodium 10mg and 20mg gastro-resistant tablets
- Reason
- Bristol Laboratories Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the batches in the table for Rabeprazole sodium 10mg and 20mg gastro-resistant tablets do not contain the most up to date safety information.
- Classification
- Class III
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2025-01-09
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/0ed21554-8ab6-475b-8990-2d066ef0961a